Key result
iMODERN trial evaluates iFR-guided immediate vs delayed CMR-guided multivessel PCI in STEMI.
Why the study?
It remains unclear whether non-culprit lesion revascularisation in STEMI patients should be performed during the index procedure or at a later stage.
RCT (n=1,146)
Open-label (with blinded evaluation of endpoints)
1:1 ratio, permuted block design per centre
Yes
Answers are grounded in this paper and cite their sources.
Multivessel revascularization strategy in STEMI remains unresolved; iMODERN will deliver the first randomized comparison of iFR- versus CMR-guided approaches.
INTRODUCTION: Recent randomised clinical trials showed benefit of non-culprit lesion revascularisation in ST-elevation myocardial infarction (STEMI) patients. However, it remains unclear whether revascularisation should be performed at the index procedure or at a later stage. METHODS AND ANALYSIS: The instantaneous wave-free ratio (iFR) Guided Multivessel Revascularisation During Percutaneous Coronary Intervention for Acute Myocardial Infarction trial is a multicentre, randomised controlled prospective open-label trial with blinded evaluation of endpoints. After successful primary percutaneous coronary intervention (PCI), eligible STEMI patients with residual non-culprit lesions are randomised, to instantaneous wave-free ratio guided treatment of non-culprit lesions during the index procedure versus deferred cardiac MR-guided management within 4 days to 6 weeks. The primary endpoint of the study is the combined occurrence of all-cause death, recurrent myocardial infarction and hospitalisation for heart failure at 12 months follow-up. Clinical follow-up includes questionnaires at 3 months and outpatient visits at 6 months and 12 months after primary PCI. Furthermore, a cost-effectiveness analysis will be performed. ETHICS AND DISSEMINATION: Permission to conduct this trial has been granted by the Medical Ethical Committee of the Amsterdam University Medical Centres (loc. VUmc, ID NL60107.029.16). The primary results of this trial will be shared in a main article and subgroup analyses or spin-off studies will be shared in secondary papers. TRIAL REGISTRATION NUMBER: NCT03298659.
No takes yet. Share an insight, caveat, or question.
Beijnink et al. (2021) conducted an RCT in ST-elevation myocardial infarction with multivessel coronary artery disease (n=1,146). Instantaneous wave-free ratio (iFR) guided treatment of non-culprit lesions during the index procedure vs. Deferred cardiac MR-guided management within 4 days to 6 weeks was evaluated on Combined occurrence of all-cause death, recurrent myocardial infarction and hospitalisation for heart failure at 12 months follow-up. The iMODERN study is an ongoing randomized controlled trial protocol designed to evaluate whether iFR-guided index procedure multivessel PCI improves clinical outcomes compared to delayed CMR-guided revascularization in STEMI patients, and has not yet reported results.
Synapse has enriched 10 related papers. Consider them for comparative context: